EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Alzheimer's biomarkers and physical functions in aging adults with and without motoric cognitive risk syndrome

Pei-Hao Chen, Sang-I Lin, Ying-Yi Liao, Gwo-Chi Hu, Fang-Yu Cheng

Experimental Gerontology · 2025

DOI: 10.1016/j.exger.2025.112975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Gerontology, 2025. Verfasst von Pei-Hao Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medicine, MacKay Medical University, New Taipei City, Taiwan; Gradua…. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Alzheimer Disease, tau Proteins, Peptide Fragments. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MacKay Medical University, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mobility impairments such as slowed gait and diminished functional capacity are increasingly recognized as early indicators of neurodegenerative processes in aging, including Alzheimer's disease. While cerebrospinal fluid and imaging biomarkers have shown links to physical decline, blood-based biomarkers offer a less invasive and more scalable alternative. However, their associations with physical performance across different stages of cognitive aging remain insufficiently explored. This study aimed to examine the cross-sectional associations between plasma amyloid beta 42 and total tau levels and physical function in older adults with normal cognition, motoric cognitive risk syndrome, and mild Alzheimer's disease. METHODS: A total of 159 community-dwelling older adults were enrolled and categorized into three cognitive groups. Plasma biomarker levels were measured using immunomagnetic reduction assays. Physical function was assessed using gait speed, Timed Up and Go, tandem stance, and dual-task walking. Generalized linear models were applied to assess associations between biomarkers and performance within each group. RESULTS: Higher plasma amyloid beta 42 levels were significantly associated with poorer Timed Up and Go performance in the full sample and in those with motoric cognitive risk syndrome. Unexpectedly, higher plasma total tau levels were positively associated with gait speed in the motoric cognitive risk group. No significant associations were observed for balance or dual-task performance. CONCLUSION: Plasma biomarkers may reflect stage-specific mobility changes in aging populations. Their integration with performance-based tests may support early identification of functional decline and guide timely interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesAlzheimer Diseasetau ProteinsPeptide FragmentsCognitive DysfunctionAgingHumansAgedMaleFemaleBiomarkersCross-Sectional StudiesAged, 80 and overWalking SpeedMiddle AgedCognition

Stichwörter der Autor:innen

Alzheimer's diseaseGait speedMobility impairmentMotoric cognitive risk syndromePhysical functionPlasma biomarkers

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsPeptide Fragmentsamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • Department of Neurology, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medicine, MacKay Medical University, New Taipei City, Taiwan; Graduate Institute of Mechanical and Electrical Engineering, National Taipei…
  • Institute of Long-term Care, College of Health and Welfare, MacKay Medical University, New Taipei City, Taiwan.
  • Department of Gerontological Health Care, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
  • Department of Rehabilitation Medicine, MacKay Memorial Hospital, Taipei, Taiwan.
  • Institute of Long-term Care, College of Health and Welfare, MacKay Medical University, New Taipei City, Taiwan. Electronic address: fycheng@mmu.edu.tw.

Förderung

  • MacKay Medical University
  • National Science and Technology Council

Zitieren

APA

Chen, P. H., Lin, S. I., Liao, Y. Y., Hu, G. C., & Cheng, F. Y. (2025). Plasma Alzheimer's biomarkers and physical functions in aging adults with and without motoric cognitive risk syndrome. Experimental Gerontology. https://doi.org/10.1016/j.exger.2025.112975

Vancouver

Chen PH, Lin SI, Liao YY, Hu GC, Cheng FY. Plasma Alzheimer's biomarkers and physical functions in aging adults with and without motoric cognitive risk syndrome. Experimental Gerontology. 2025. doi:10.1016/j.exger.2025.112975

BibTeX
@article{Chen2025,
  author = {Chen, Pei-Hao and Lin, Sang-I and Liao, Ying-Yi and Hu, Gwo-Chi and Cheng, Fang-Yu},
  title = {Plasma Alzheimer's biomarkers and physical functions in aging adults with and without motoric cognitive risk syndrome},
  journal = {Experimental Gerontology},
  year = {2025},
  doi = {10.1016/j.exger.2025.112975}
}
Kostenlos starten →